Anhydrous Dibasic Calcium Phosphate has wide range of applications across various industries like food, pharmaceuticals and animal feed which will drive its demand at highest pace. Anhydrous Dibasic Calcium Phosphate is a fine, white, practically odorless powder that is considered as an inert, non-toxic salt. It is moderately soluble in water and stable in air and is commonly used as a calcium supplement, buffering agent, and for its emulsifying properties in food. It acts as an important source of dietary calcium and phosphorus and can enhance bone mineralization and strength. It finds wide applications across various industries like food, pharmaceuticals, animal feed additives and others due to its versatile properties. The Global Anhydrous Dibasic Calcium Phosphate Market is estimated to be valued at US$ 245.96 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the Anhydrous Dibasic Calcium Phosphate are Pfizer, Sanofi, New England Biolabs, GlaxoSmithKline plc, GenScript, Thermo Fisher Scientific, Inc. Key players are focusing on acquiring smaller companies to expand their portfolio and geographical footprint. Second, growing usage of Anhydrous Dibasic Calcium Phosphate Market Demand as a dietary supplement across the world is expected to drive its demand at highest pace over coming years. With increasing health awareness among people, demand for calcium and phosphorus supplements is increasing rapidly which is propelling the market growth. Third, companies are investing heavily in research & development of novel and advanced technologies to develop high purity Anhydrous Dibasic Calcium Phosphate which can improve its functionalities. Ongoing technological advancements are helping to discover new applications of these supplements. Market Trends The Anhydrous Dibasic Calcium Phosphate market is witnessing trend of portfolio expansion through mergers and acquisitions. Major companies are focused on acquiring smaller local players to expand their global footprint and product portfolio. Other trend is growing demand for specialty grades Anhydrous Dibasic Calcium Phosphate. With increasing usage across various end use industries, demand for high purity specialty grades with certain customized specifications is on the rise. This is prompting companies to develop innovative production technologies for specialty grades. Market Opportunities Growing demand from emerging economies: Emerging countries like India, China, Brazil are expected to offer huge growth opportunities owing to changing lifestyle, rising incomes and growing health consciousness. Second, new application development: Companies are exploring new potential application areas of Anhydrous Dibasic Calcium Phosphate like cosmetics, toothpaste etc. to further boost its demand. Impact of COVID-19 on Anhydrous Dibasic Calcium Phosphate Market Growth The COVID-19 pandemic had a significant impact on the growth of the Anhydrous Dibasic Calcium Phosphate market initially. Strict lockdowns imposed globally disrupted supply chains, halted production operations, and reduced demand from end-use industries like food & beverages. This led to a decline in the market growth rate in 2020. However, as restrictions eased in late 2020 and 2021, the market started recovering gradually. The outbreak highlighted the importance of calcium and phosphorus for bone and teeth health. This increased the focus on immunity-boosting supplements containing Anhydrous Dibasic Calcium Phosphate. With growing health consciousness, the demand for nutraceuticals and functional foods incorporated with this mineral salt witnessed an upsurge post-pandemic as well. Furthermore, rebuilding activities in economies also propelled the requirement from various industrial applications in the latter half of the forecast period. Nevertheless, uncertain economic conditions and inflationary pressure remained challenges for market players. Strong distribution networks and innovative product launches helped key manufacturers to counter risks and regain losses during the pandemic. Geographical Regions with Highest Market Concentration The Asia Pacific region accounts for the largest share of the global Anhydrous Dibasic Calcium Phosphate market in terms of value. This is attributed to the burgeoning food processing and pharmaceutical industries, growing health awareness, increasing disposable incomes, and rising meat consumption in densely populated countries like India and China. Expansion of major multinational companies and availability of raw materials also contribute to the dominant position of Asia Pacific. Moreover, changing lifestyles and rapidly growing middle-class population fuel the demand for nutritious processed food products and dietary supplements fortified with this mineral salt. Fastest Growing Region for Anhydrous Dibasic Calcium Phosphate Market The Middle East and Africa region is expected to register the fastest growth in the Anhydrous Dibasic Calcium Phosphate market during the forecast period. This is due to robust economic development, rising health expenditures, expanding distribution networks of international brands, and increasing consumption of packaged food and animal feed. Government initiatives to promote local manufacturing also spur market growth. Evolving retail landscape with growing penetration of e-commerce amplifies the sales of supplements and functional foods. Additionally, the presence of key mineral reserves and investments by global producers to tap the largely untapped African market strengthen regional market dynamics. Get More Insights on Anhydrous Dibasic Calcium Phosphate Market
0 Comments
Inflammatory bowel disease (IBD) encompasses chronic inflammation occurring in the small and large intestines. The two major types of IBD include ulcerative colitis and Crohn's disease. Inflammatory bowel diseases require lifelong treatment and management as there are currently no cures available for these diseases. Drugs used for treatment aim to induce and maintain remission. The global inflammatory bowel disease market is estimated to be valued at US$ 13.7 billion in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The increasing prevalence of inflammatory bowel diseases (IBD) presents a major market opportunity. According to estimates, over 1.5 million Americans suffer from IBD including ulcerative colitis and Crohn's disease. The prevalence of IBD is also rising globally with highest rates observed in developed countries. Advances in medical diagnosis have helped boost disease detection rates further. With no a cure currently available, patients require life-long treatment regimens involving drug therapies and surgery in some severe cases. The growing patient pool diagnosed with these chronic ailments ensures a consistent demand for various drugs and therapies in the inflammatory bowel disease market over the forecast period. Porter's Analysis Threat of new entrants: The threat of new entrants in the inflammatory bowel disease market is moderate due to high investment required and stringent regulations. Bargaining power of buyers: The bargaining power of buyers in the inflammatory bowel disease market is high as there are many established treatment options available. Bargaining power of suppliers: The bargaining power of suppliers in the inflammatory bowel disease market is low as there are many manufacturers and suppliers. Threat of new substitutes: The threat of new substitutes in the inflammatory bowel disease market is moderate as new treatment options are continuously emerging. Competitive rivalry: The competitive rivalry in the inflammatory bowel disease market is high due to presence of many established brands. SWOT Analysis Strengths: Extensive R&D, wide product portfolio, increasing awareness. Weaknesses: High cost of treatment, side effects of drugs, social stigma. Opportunities: Emerging economies, favorable reimbursement policies, online patient support groups. Threats: Patent expiries, stringent regulations, alternative treatment options. Key Takeaways Global Inflammatory Bowel Disease Market Size is expected to witness high growth during the forecast period of 2023 to 2030. Regional analysis: North America is expected to dominate the global inflammatory bowel disease market during the forecast period owing to increasing prevalence of IBD, rising research funding, and availability of advanced treatment options in the region. Europe is also estimated to account for a significant share in the market due to growing awareness about IBD. Asia Pacific is anticipated to witness fastest growth due to improving healthcare infrastructure and rapidly changing dietary patterns. Key players: Key players operating in the inflammatory bowel disease market are Johnson & Johnson, AbbVie, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Pfizer, Allergan, Janssen Biotech, and Novartis AG. Johnson & Johnson dominates the market due to its wide product portfolio for both ulcerative colitis and Crohn's disease treatment. Get More Insights on this Topic- https://www.rapidwebwire.com/inflammatory-bowel-disease-market-value-insights-and-forecast/ Pet insurance provides reimbursement for veterinary care including surgical procedures, prescriptions, and other pet wellness costs. It protects pet owners against unexpected vet bills and allows them to focus on their pets' recovery instead of searching for funds. The market has seen an increase in products tailored for specialty care including cancer treatment and wellness plans. Pet parents have become more aware about maintaining adequate coverage for their furry companions as they consider them important family members. The global pet insurance market is estimated to be valued at US$ 9.59 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key drivers for the pet insurance market is the rising expenditure on pets. According to the American Pet Products Association, Americans spent over $99 billion on their pets in 2021 alone. Out-of-pocket costs for unforeseen medical care can be hefty driving more owners to opt for insurance coverage. Additionally, pet owners are increasingly willing to spare no expense for their pets' health and well-being. The Covid-19 pandemic reinforced human-animal bonds and the notion of pets as companions providing emotional support. This has prompted greater prioritization of pet wellness translating to demand for financial protection plans like insurance. Accident and illness policies tend to be the most popular accounting for a large share of the market. The expanding pet population and disposable income levels especially in developing economies are projected to fuel the pet insurance sector globally over the coming years. SWOT Analysis Strength: Pet insurance provides financial protection for owners against unexpected veterinary bills for accidents and illnesses. It lowers financial burden for treatments like cancer surgery or ACL repairs, which can cost thousands. Many pet insurance plans cover routine care, dental procedures, prescription medications and more. Weakness: Premium costs can increase annually as pets age and health risks rise. Not all medical conditions are covered, pre-existing conditions may not be eligible for coverage. Deductibles require owners to pay out of pocket before reimbursements start. Opportunity: Growing awareness among pet owners regarding importance of preventive care and financial security is increasing demand for pet insurance plans. Untapped potential remains in developing regions to further educate owners. New wellness or discount policies could drive additional enrollments. Threats: Economic slowdowns may force budget-conscious owners to cancel or reduce coverage. New healthcare alternatives like wellness plans pose price competition. Natural disasters and disease outbreaks increase medical costs across the industry. Key Takeaways Global Pet Insurance Market Size is expected to witness high growth. The global pet insurance market is estimated to be valued at US$ 9.59 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030. Regional analysis related content comprises the North American region currently dominates the pet insurance market owing to high pet adoption and ownership rates in countries like the US and Canada. Growing awareness about pet wellness and rising spending on pet care is also driving greater insurance adoption in the region. Key players related content comprises Key players operating in the pet insurance market are Cargill Aqua Nutrition, Skretting (Nutreco), Biomar, Alltech, Ridley Corporation Limited, CP Group, Charoen Pokphand Foods (CPF), Nutriad International, BioMar Group, Nutra Blend LLC, Guangdong Haid Group Co., Ltd., Tongwei Group, Avanti Feeds Limited, Nutrivet, BRF S.A. Get More Insights on this Topic- https://www.marketwebjournal.com/pet-insurance-market-future-trends-and-analysis/ Oxygen Therapy Market is Estimated to Witness High Growth Owing to Rising Prevalence of COPD12/25/2023 Oxygen therapy includes the use of oxygen as a medical treatment. It is used therapeutically to treat low blood oxygen levels, as in COPD. Oxygen therapy products include oxygen concentrators, oxygen cylinders and liquid oxygen devices. These products are used at hospitals, nursing facilities and at home. The global oxygen therapy market is estimated to be valued at US$ 36.75 Bn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key drivers fuelling the growth of the oxygen therapy market is the rising prevalence of chronic obstructive pulmonary disease (COPD). As perestimates, over 328 million people worldwide suffer from COPD. COPD patients experience symptoms like shortness of breath, exercise limitations and chronic cough due to reduced airflow in the lungs. Oxygen therapy plays a crucial role in the management and treatment of COPD as it reduces breathlessness and improves patient survival. The adoption of oxygen therapy is expected to increase substantially owing to growing COPD burden globally. Portability and home care features of oxygen concentrators and cylinders also contribute to increased demand. SWOT Analysis Strength: Oxygen therapy helps patients suffering from various respiratory diseases breathe more easily and get their required oxygen levels. It can prevent infections and complications caused due to low oxygen levels in the blood. The market offers various portable oxygen concentrators and liquid oxygen devices that provide flexibility to patients. Weakness: Oxygen therapy is a long-term treatment and many patients may find it difficult to be dependent on oxygen cylinders or devices for extended periods. The devices also require regular maintenance and replacements that increase the overall treatment cost. Opportunity: Rising global pollution levels and increasing number of smokers are leading to a steady rise in cases of COPD and other respiratory illnesses. This wide patient pool worldwide presents significant growth opportunities for players in the oxygen therapy market. Growing medical tourism in developing nations is another major opportunity. Threats: Stringent regulatory approvals for new oxygen therapy devices may delay their market launch. reimbursement policies and coverage changes can impact the demand. Growing preference for alternative respiratory therapies like inhalers and nebulizers also poses a threat. Key Takeaways Global Oxygen Therapy Market Demand is expected to witness high growth at a CAGR of 5% during the forecast period of 2023 to 2030. The market size for 2023 is estimated at US$ 36.75 billion. Regional analysis: North America accounted for the largest share of over 35% in the global market in 2023 due to growing prevalence of COPD along with rapid adoption of technologically advanced oxygen source devices. Asia Pacific is projected witness the fastest growth owing to rising healthcare expenditures, growing medical tourism industry and increasing pollution levels. Key players: Key players operating in the oxygen therapy market are Ottobock, Össur hf, Teh Lin Pros. & Ortho. Inc., Shijiazhuang Wonderfu Rehabilitation Device Technology Co., Ltd., Hebei Baisite Prosthetic Orthotic Technology Co., Ltd., Beijing Jingbo Prosthetics & Orthotics Technical Co., Ltd., Nobel China Limited, Shijiazhuang Aofeite Import & Export Co., Ltd., e-Life International Co., Ltd., Rehan International Co., Ltd., and Xiamen Huakang Orthopedic Co., Ltd. Get More Insights on this Topic- https://www.dailyprbulletin.com/oxygen-therapy-market-growth-insights-and-forecast/ |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
April 2024
Categories
All
|